Symbiotic and antibiotic interactions between gut commensal microbiota and host immune system

Medicina (Lithuania)

Volumn 51, Issue 2, 2015, Pages 69-75

  Malys, Mantas Kazimieras ^a   Campbell, Laura ^b   Malys, Naglis ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

B cells; Commensal microbiota; Dysbiosis; Immune system; T cells

Indexed keywords

ANTIINFECTIVE AGENT; IMMUNOGLOBULIN A;

ADAPTIVE IMMUNITY; ANIMAL; B LYMPHOCYTE; DIET; DRUG EFFECTS; GASTROINTESTINAL TRACT; GENETICS; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; INTESTINE FLORA; MICROBIOLOGY; MOUSE; REGULATORY T LYMPHOCYTE;

ADAPTIVE IMMUNITY; ANIMALS; ANTI-BACTERIAL AGENTS; B-LYMPHOCYTES; DIET; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; IMMUNOGLOBULIN A; MICE; T-LYMPHOCYTES, REGULATORY;

EID: 84952003224     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.medici.2015.03.001     Document Type: Review

References (73)

1. Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
2. Fukuda S., Ohno H. Gut microbiome and metabolic diseases. Semin Immunopathol 2014, 36:103-114.
3. Tremaroli V., Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012, 489:242-248.
4. Sekirov I., Russell S.L., Antunes L.C., Finlay B.B. Gut microbiota in health and disease. Physiol Rev 2010, 90:859-904.
5. Pérez-Cobas A.E., Gosalbes M.J., Friedrichs A., Knecht H., Artacho A., Eismann K., et al. Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut 2013, 62:1591-1601.
6. Willing B.P., Russell S.L., Finlay B.B. Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat Rev Microbiol 2011, 9:233-243.
7. Maurice C.F., Haiser H.J., Turnbaugh P.J. Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell 2013, 152:39-50.
8. Macfarlane S. Antibiotic treatments and microbes in the gut. Environ Microbiol 2014, 16:919-924.
9. Ubeda C., Bucci V., Caballero S., Djukovic A., Toussaint N.C., Equinda M., et al. Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect Immun 2013, 81:965-973.
10. Stecher B., Chaffron S., Käppeli R., Hapfelmeier S., Freedrich S., Weber T.C., et al. Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog 2010, 6:e1000711.
11. Stecher B., Robbiani R., Walker A.W., Westendorf A.M., Barthel M., Kremer M., et al. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol 2007, 5:2177-2189.
12. Endt K., Stecher B., Chaffron S., Slack E., Tchitchek N., Benecke A., et al. The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella diarrhea. PLoS Pathog 2010, 6:e1001097.
13. Lee J., Mo J.H., Katakura K., Alkalay I., Rucker A.N., Liu Y.T., et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 2006, 8:1327-1336.
14. Tien M.T., Girardin S.E., Regnault B., Le Bourhis L., Dillies M.A., Coppée J.Y., et al. Anti-inflammatory effect of Lactobacillus casei on Shigella infected human intestinal epithelial cells. J Immunol 2006, 176:1228-1237.
15. Fleming L.L., Floch M.H. Digestion and absorption of fiber carbohydrate in the colon. Am J Gastroenterol 1986, 81:507-511.
16. Segain J.P., Raingeard de la Blétière D., Bourreille A., Leray V., Gervois N., Rosales C., et al. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut 2000, 47:397-403.
17. Vanhoutvin S.A., Troost F.J., Hamer H.M., Lindsey P.J., Koek G.H., Jonkers D.M., et al. Butyrate-induced transcriptional changes in human colonic mucosa. PLoS ONE 2009, 4:e6759.
18. Vijay-Kumar M., Aitken J.D., Carvalho F.A., Cullender T.C., Mwangi S., Srinivasan S., et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010, 328:228-231.
19. Sonnenberg G.F., Artis D. Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease. Immunity 2012, 37:601-610.
20. O'Reilly S. Innate immunity in systemic sclerosis pathogenesis. Clin Sci (Lond) 2014, 126:329-337.
21. Ivanov I.I., Frutos Rde L., Manel N., Yoshinaga K., Rifkin D.B., Sartor R.B., et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008, 4:337-349.
22. Gaboriau-Routhiau V., Rakotobe S., Lécuyer E., Mulder I., Lan A., Bridonneau C., et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009, 31:677-689.
23. Ivanov I.I., Atarashi K., Manel N., Brodie E.L., Shima T., Karaoz U., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
24. Klaasen H.L., Koopman J.P., Van den Brink M.E., Bakker M.H., Poelma F.G., Beynen A.C. Intestinal, segmented, filamentous bacteria in a wide range of vertebrate species. Lab Anim 1993, 27:141-150.
25. Wu H.J., Ivanov I.I., Darce J., Hattori K., Shima T., Umesaki Y., et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010, 32:815-827.
26. Lee Y.K., Menezes J.S., Umesaki Y., Mazmanian S.K. Microbes and health sackler colloquium: proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2011, 108:4615-4622.
27. Cerf-Bensussan N., Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes?. Nat Rev Immunol 2010, 10:735-744.
28. McGeachy M.J., Bak-Jensen K.S., Chen Y., Tato C.M., Blumenschein W., McClanahan T., et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 2007, 8:1390-1397.
29. El-Behi M., Ciric B., Dai H., Yan Y., Cullimore M., Safavi F., et al. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat Immunol 2011, 12:568-575.
30. Esplugues E., Huber S., Gagliani N., Hauser A.E., Town T., Wan Y.Y., et al. Control of TH17 cells occurs in the small intestine. Nature 2011, 475:514-518.
31. Huber S., Gagliani N., Flavell R.A. Life, death, and miracles: Th17 cells in the intestine. Eur J Immunol 2012, 42:2238-2245.
32. Atarashi K., Tanoue T., Shima T., Imaoka A., Kuwahara T., Momose Y., et al. Induction of colonic regulatory T cells by Indigenous Clostridium species. Science 2011, 331:337-341.
33. Nagano Y., Itoh K., Honda K. The induction of Treg cells by gut-indigenous Clostridium. Curr Opin Immunol 2012, 24:392-397.
34. Atarashi K., Tanoue T., Oshima K., Suda W., Nagano Y., Nishikawa H., et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013, 500:232-236.
35. Lathrop S.K., Bloom S.M., Rao S.M., Nutsch K., Lio C.W., Santacruz N., et al. Peripheral education of the immune system by colonic microbiota. Nature 2011, 478:250-254.
36. Kuhn K.A., Stappenbeck T.S. Peripheral education of the immune system by the colonic microbiota. Semin Immunol 2013, 25:364-369.
37. Thornton A.M., Korty P.E., Tran D.Q., Wohlfert E.A., Murray P.E., Belkaid Y., et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymicderived from peripherally induced Foxp3+ T regulatory cells. J Immunol 2010, 184:3433-3441.
38. Rubtsov Y.P., Rasmussen J.P., Chi E.Y., Fontenot J., Castelli L., Ye X., et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008, 28:546-558.
39. Di Giacinto C., Marinaro M., Sanchez M., Strober W., Boirivant M. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol 2005, 174:3237-3246.
40. Round J.L., Lee S.M., Li J., Tran G., Jabri B., Chatila T.A., et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 2011, 332:974-977.
41. Suzuki K., Meek B., Doi Y., Muramatsu M., Chiba T., Honjo T., et al. Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc Natl Acad Sci U S A 2004, 101:1981-1986.
42. Obata T., Goto Y., Kunisawa J., Sato S., Sakamoto M., Setoyama H., et al. Indigenous opportunistic bacteria inhabit mammalian gut-associated lymphoid tissues and share a mucosal antibody-mediated symbiosis. Proc Natl Acad Sci U S A 2010, 107:7419-7424.
43. Peterson D.A., McNulty N.P., Guruge J.L., Gordon J.I. IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe 2007, 2:328-339.
44. Belkaid Y., Hand T.W. Role of the microbiota in immunity and inflammation. Cell 2014, 157(1):121-141.
45. Power S.E., O'Toole P.W., Stanton C., Ross R.P., Fitzgerald G.F. Intestinal microbiota, diet and health. Br J Nutr 2014, 111(3):387-402.
46. Belkaid Y., Naik S. Compartmentalized and systemic control of tissue immunity by commensals. Nat Immunol 2013, 14:646-653.
47. Frank D.N., St.Amand A.L., Feldman R.A., Boedeker E.C., Harpaz N., Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007, 104:13780-13785.
48. Arpaia N., Campbell C., Fan X., Dikiy S., van der Veeken J., deRoos P., et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013, 504:451-455.
49. Dicksved J., Halfvarson J., Rosenquist M., Järnerot G., Tysk C., Apajalahti J., et al. Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J 2008, 2(7):716-727.
50. Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermúdez-Humarán L.G., Gratadoux J.J., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008, 105(43):16731-16736.
51. Nadal I., Donant E., Ribes-Koninckx C., Calabuig M., Sanz Y. Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J Med Microbiol 2007, 56(12):1669-1674.
52. Scher J.U., Sczesnak A., Longman R.S., Segata N., Ubeda C., Bielski C., et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife 2013, 2:e01202.
53. Ochoa-Repáraz J., Mielcarz D.W., Wang Y., Begum-Haque S., Dasgupta S., Kasper D.L., et al. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol 2010, 3(5):487-495.
54. Round J.L., Mazmanian S.K. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009, 9:313-323.
55. Hsiao E.Y., McBride S.W., Hsien S., Sharon G., Hyde E.R., McCue T., et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013, 155(7):1451-1463.
56. Marshall B.J., Warren J.R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984, 1:1311-1315.
57. Ley R.E., Bäckhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 2005, 102:11070-11075.
58. Karlsson F.H., Tremaroli V., Nookaew I., Bergstrom G., Behre C.J., Fagerberg B., et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 2013, 498:99-103.
59. Berg A.M., Kelly C.P., Farraye F.A. Clostridium difficile infection in the inflammatory bowel disease patient. Inflamm Bowel Dis 2013, 19:194-204.
60. Rolhion N., Darfeuille-Michaud A. Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm Bowel Dis 2007, 13(10):1277-1283.
61. Cahill R.J., Foltz C.J., Fox J.G., Dangler C.A., Powrie F., Schauer D.B. Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect Immun 1997, 65(8):3126-3131.
62. Bloom S.M., Bijanki V.N., Nava G.M., Sun L., Malvin N.P., Donermeyer D.L., et al. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe 2011, 9:390-403.
63. Elson C.O., Cong Y. Host-microbiota interactions in inflammatory bowel disease. Gut Microb 2012, 3:332-344.
64. Alvarado I., Abel-Santos E. How enteric pathogens know they hit the sweet spot. Future Microbiol 2014, 9(1):13-16.
65. Ng K.M., Ferreyra J.A., Higginbottom S.K., Lynch J.B., Kashyap P.C., Gopinath S., et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 2013, 502:96-99.
66. Plummer S., Weaver M.A., Harris J.C., Dee P., Hunter J. Clostridium difficile pilot study: effects of probiotic therapy: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int Microbial 2004, 7:59-62.
67. Guo B., Harstall C., Louie T., Veldhuyzen van Zanten S., Dieleman L.A. Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease. Aliment Pharmacol Ther 2012, 35:865-875.
68. Van den Abbeele P., Verstraete W., El Aidy S., Geirnaert A., Van de Wiele T. Prebiotics, faecal transplants and microbial network units to stimulate biodiversity of the human gut microbiome. Microb Biotechnol 2013, 6:335-340.
69. Paasché S. Fecal microbiota transplantation: an innovative approach to treating Clostridium difficile disease. JAAPA 2013, 26:46-49.
70. Buffie C.G., Pamer E.G. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 2013, 13:790-801.
71. Rachmilewitz D., Katakura K., Karmeli F., Hayashi T., Reinus C., Rudensky B., et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004, 126:530-628.
72. Lee J., Rachmilewitz D., Raz E. Homeostatic effects of TLR9 signaling in experimental colitis. Ann N Y Acad Sci 2006, 1072:351-355.
73. Petersen C., Round J.L. Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol 2014, 16(7):1024-1033.